EANS-Voting Rights: Marinomed Biotech AG
Publication of a participation
notification according to art. 135 para. 2 Stock Exchange Act
-------------------------------------------------------------------------------- Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Name: Erste Asset Management GmbH City: Wien Country: Österreich 4. Name of shareholder(s): Erste Asset Management GmbH 5. Date on which the threshold was crossed or reached: 18.10.2019 6. Total positions ______________________________________________________________________________ | | % of voting | % of voting | | | | |rights attached|rights through |Total of both |Total number of| | |to shares (7.A)|financial/other| in % (7.A + | voting rights | | | | instruments | 7.B) | of issuer | |_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________| | Resulting | | | | | | situation on | | | | | | the date on | | | | | |which threshold| 7.71 % | 0.00 % | 7.71 % | 1 469 772 | | was crossed / | | | | | | reached | | | | | |_______________|_______________|_______________|______________|_______________| | Position of | | | | | | previous | | | | | | notification | 0.00 % | 0.00 % | 0.00 % | | |(if applicable)| | | | | |_______________|_______________|_______________|______________|_______________| Details 7. Notified details of the resulting situation: ______________________________________________________________________________ |A: Voting rights attached to shares | |______________________________________________________________________________| | | Number of voting rights | % of voting rights | | |_______________________________|________________________________| | | Direct | Indirect | Direct | Indirect | | ISIN Code |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG | | | 2018) | 2018) | 2018) | 2018) | |_____________|_______________|_______________|_______________|________________| |ATMARINOMED6 | 113 317| | 7.71 %| | |_____________|_______________|_______________|_______________|________________| | SUBTOTAL A | 113 317 | 7.71 % | |_____________|_______________________________|________________________________| ______________________________________________________________________________ |B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG | |2018 | |______________________________________________________________________________| | | | |Number of voting | | | | | | rights that may | | | | | | be | | | Type of |Expiration Date|Exercise Period|acquired if the | % of voting | | instrument | | | instrument is | rights | | | | | exercised | | |_____________|_______________|_______________|_________________|______________| | | | SUBTOTAL B.1 | | | |_____________|_______________|_______________|_________________|______________| _____________________________________________________________________________ |B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG | |2018 | |_____________________________________________________________________________| | Type of | Expiration | Exercise | Physical / | Number of |% of voting | |instrument | Date | Period | Cash |voting rights| rights | |___________|____________|___________|_Settlement__|_____________|____________| | | | |SUBTOTAL B.2 | | | |___________|____________|___________|_____________|_____________|____________| 8. Information in relation to the person subject to the notification obligation: Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. 9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Additional comments: The voting rights held by Erste Asset Management GmbH as stated in section 8 are not held directly but by the investment funds managed by the management company. They are therefore not holdings of the management company. Note of the Issuer: This is a translation of the received shareholder notification in German language. The translation into English is not binding. Further inquiry note: Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at end of announcement euro adhoc -------------------------------------------------------------------------------- issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: ATMARINOMED6, AT0000A1WD52 indexes: stockmarkets: Wien language: English
Original content of: Marinomed Biotech AG, transmitted by news aktuell